326
Participants
Start Date
December 31, 2008
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
LCP-Tacro
LCP-Tacro tablets will be administered orally QD, at the same time in the morning to maintain trough levels at 5-15 ng/ML. Subsequent doses will be adjusted according to whole blood tacrolimus trough levels. LCP-Tarco (tacrolimus) tablets provided in 0.5 mg, 1 mg, 2 mg, and 5 mg tablets.
Prograf
Oral prograf doses will be given BID (in the morning and evening), to maintain trough levels of 5- 15 ng/mL. Prograf capsules (tacrolimus) capsules, twice daily oral, provided in 0.5 mg, 1 mg, and 5 mg capsules.
California Institute of Renal Research/ Sharp Memorial, San Diego
Lead Sponsor
Collaborators (1)
PPD Development, LP
INDUSTRY
Veloxis Pharmaceuticals
INDUSTRY